Home
Jan Didrik Schjøtt's picture

Jan Didrik Schjøtt

Professor
  • E-mailJan.Schjott@uib.no
  • Phone+47 55 97 30 93
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2022). Serum or Plasma for Quantification of Direct Oral Anticoagulants? Therapeutic Drug Monitoring.
  • Show author(s) (2022). A patient with sepsis-induced multiorgan failure and increasing serum methadone concentration: a case study. Therapeutic Drug Monitoring.
  • Show author(s) (2021). Ultrasound and Microbubbles Enhance Uptake of Doxorubicin in Murine Kidneys. Pharmaceutics.
  • Show author(s) (2021). Review of Clinical Questions Submitted to Norwegian Drug Information Centres Concerning Administration and Dosage to Older Patients of Relevance to Patient-Central Care. Pharmaceutics.
  • Show author(s) (2021). Quetiapine, Misuse and dependency: A case-series of questions to a Norwegian network of drug information centers. Drug, Healthcare and Patient Safety. 151-157.
  • Show author(s) (2020). Ultrasound‐ and microbubble‐assisted gemcitabine delivery to pancreatic cancer cells. Pharmaceutics. 1-15.
  • Show author(s) (2020). Rethinking rehabilitation after percutaneous coronary intervention: a protocol of a multicentre cohort study on continuity of care, health literacy, adherence and costs at all care levels (the CONCARDPCI). BMJ Open. e031995.
  • Show author(s) (2020). Perception of prescribing factors and purchase statistics of non-steroidal anti-inflammatory drugs in an orthopedic clinic. BMC Research Notes. 1-6.
  • Show author(s) (2020). Intracellular cytidine deaminase regulates gemcitabine metabolism in pancreatic cancer cell lines. Drug Metabolism And Disposition. 153-158.
  • Show author(s) (2019). Analysis of consensus among drug interaction databases with regard to combinations of psychotropics. Basic & Clinical Pharmacology & Toxicology. 1-7.
  • Show author(s) (2019). A retrospective comparison of inappropriate prescribing of psychotropics in three Norwegian nursing homes in 2000 and 2016 with prescribing quality indicators. BMC Medical Informatics and Decision Making. 1-11.
  • Show author(s) (2018). Use of references in responses from Scandinavian drug information centres. Medicines.
  • Show author(s) (2018). The possibility of therapeutic drug monitoring of the most important interactions in nursing homes. Current Clinical Pharmacology.
  • Show author(s) (2018). Rituximab serum concentrations and anti-rituximab antibodies during B-cell depletion therapy for myalgic encephalopathy/chronic fatigue syndrome. Clinical Therapeutics. 9.
  • Show author(s) (2018). Challenges adhering to a medication regimen following first-time percutaneous coronary intervention: A patient perspective. International Journal of Nursing Studies. 16-24.
  • Show author(s) (2018). Analysis of questions about use of drugs in breastfeeding to Norwegian drug information centres . International Breastfeeding Journal. 1-9.
  • Show author(s) (2017). Quality assessment of structure and language elements of written responses given by seven Scandinavian drug information centres. European Journal of Clinical Pharmacology. 623-631.
  • Show author(s) (2016). Relationship Between Time Consumption and Quality of Responses to Drug-Related Queries:A Study From Seven Drug Information Centers in Scandinavia. Clinical Therapeutics. 1738-1749.
  • Show author(s) (2016). Physicians' Perception of Teratogenic Risk and Confidence in Prescribing Drugs in Pregnancy - Influence of Norwegian Drug Information Centers. Clinical Therapeutics. 1102-1108.
  • Show author(s) (2016). Drug information services today: current role and future perspectives in rational drug therapy. Clinical Therapeutics. 414-421.
  • Show author(s) (2016). Antipsychotic drugs and risk of hip fracture among people older than 60 years in Norway. Journal of The American Geriatrics Society. 1203-1209.
  • Show author(s) (2016). A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer. Journal of Controlled Release. 172-181.
  • Show author(s) (2015). Preanalytical stability of gemcitabine and its metabolite 2', 2'-difluoro-2'-deoxyuridine in whole blood-assessed by liquid chromatography tandem mass spectrometry. Journal of Pharmaceutical Sciences. 4427-4432.
  • Show author(s) (2015). Liquid chromatography/tandem mass spectrometry method for simultaneous quantification of eight endogenous nucleotides and the intracellular gemcitabine metabolite dFdCTP in human peripheral blood mononuclear cells. Journal of chromatography. B. 212-220.
  • Show author(s) (2015). Cross-reactivity of the CEDIA buprenorphine assay in drugs-of-abuse screening: influence of dose and metabolites of opioids. Substance Abuse and Rehabilitation. 131-139.
  • Show author(s) (2014). Questions about complementary and alternative medicine to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive pilot study. BMC Complementary and Alternative Medicine.
  • Show author(s) (2014). Myocardial injury in a 41-year-old male treated with metylphenidate: a case report. BMC Research Notes.
  • Show author(s) (2014). Morphine enhances doxorubicin-induced cardiotoxicity in the rat. Cardiovascular Toxicology. 251-259.
  • Show author(s) (2014). Joint medicine-information and pharmacovigilance services could improve detection and communication about drug-safety problems. Drug, Healthcare and Patient Safety. 89-92.
  • Show author(s) (2014). Factors associated with time consumption when answering drug-related queries to Scandinavian drug information centres: a multi-centre study. European Journal of Clinical Pharmacology. 1395-1401.
  • Show author(s) (2014). Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat. BMC Pharmacology & Toxicology. 8 pages.
  • Show author(s) (2013). Teratogenic risk perception and confidence in use of medicines in pairs of pregnant women and general practitioners based on patient information leaflets. Drug Safety. 481-489.
  • Show author(s) (2013). A short-time model to study relevant indices of cardiotoxicity of doxorubicin in the rat. Toxicology Mechanisms and Methods. 412-418.
  • Show author(s) (2012). Risk perception and medicines information needs in pregnant women with epilepsy - A qualitative study. Seizure. 597-602.
  • Show author(s) (2012). En retrospektiv analyse av tannlegehenvendelser til regionale legemiddelinformasjonssentre (RELIS). Den norske tannlegeforenings tidende. 284-288.
  • Show author(s) (2012). A question–answer pair (QAP) database integrated with websites to answer complex questions submitted to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive study. BMJ Open. 6 pages.
  • Show author(s) (2012). A Blended Learning Course Design in Clinical Pharmacology for Post-graduate Dental Students. Open Dentistry Journal. 182-187.
  • Show author(s) (2011). Prevention of urinary tract infections in nursing homes: lack of evidence-based prescription? BMC Geriatrics. 6 pages.
  • Show author(s) (2011). Hvordan er kvaliteten på omtalen av interaksjoner i Felleskatalogen? Norsk Farmaceutisk Tidsskrift. 20-24.
  • Show author(s) (2011). Clinical characteristics of patients with drug hypersensitivity in Norway: a single-centre study. Pharmacoepidemiology and Drug Safety. 506-513.
  • Show author(s) (2010). Which factors predict the time spent answering queries to a drug information centre? Pharmacy World & Science (PWS). 799-804.
  • Show author(s) (2010). How are antibacterials used in nursing homes? Results from a point-prevalence prescription study in 44 Norwegian nursing homes. Pharmacoepidemiology and Drug Safety. 1025-1030.
  • Show author(s) (2009). Hepatitis Caused by Lotus-f3? Basic & Clinical Pharmacology & Toxicology. 414-416.
  • Show author(s) (2009). Drug use in pregnancy-physicians' evaluation of quality and clinical impact of drug information centres. European Journal of Clinical Pharmacology. 303-308.
  • Show author(s) (2008). Advice on drug safety in pregnancy - Are there differences between commonly used sources of information? Drug Safety. 799-806.
  • Show author(s) (2006). Pretreatment with tamoxifen does not change acute epirubicin cardiotoxicity in rats. Basic & Clinical Pharmacology & Toxicology. 231-234.
  • Show author(s) (2003). Tamoxifen administration and metabolism in nude mice and nude rats. Journal of Steroid Biochemistry and Molecular Biology. 361-367.
  • Show author(s) (2003). Bruk av sovemidler på alders- og sykehjem i Hordaland og Sogn og Fjordane. Tidsskrift for Den norske legeforening. 1068-1069.
  • Show author(s) (2002). Quality and impact of problem-oriented drug information: a method to change clinical practice among physicians? European Journal of Clinical Pharmacology. 897-902.
  • Show author(s) (2002). Egenvurdering av arbeidsmiljø, og erfaringer med jobbtilpasning blant bussjåfører. Tidsskrift for Den norske legeforening. 797-800.
  • Show author(s) (2001). Polypharmacy among patients admitted to hospital with rheumatic diseases. Pharmacy World & Science (PWS). 153-158.
  • Show author(s) (2001). Polypharmacy among patients admitted to hospital with rheumatic diseases. Pharmacy World & Science (PWS). 153-158.
  • Show author(s) (2001). Assessing the effects of an intervention by a pharmacist on prescribing and administration of hypnotics in nursing homes. Pharmacy World & Science (PWS). 227-231.
  • Show author(s) (2000). Protective effects of repetitive injections of radiographic contrast media on the subsequent tolerance to ischemia in the isolated rat heart. Cardiovascular and Interventional Radiology. 433-471.
  • Show author(s) (2000). Hyperosmotic perfusion of the beating rat heart and the role of the Na+/K+/2Cl- co-transporter and the Na+/H+ exchanger. Basic Research in Cardiology. 19-27.
  • Show author(s) (2000). Hva spør helsepersonell RELIS VEST om og hvor fornøyde er de med svarene? Tidsskrift for Den norske legeforening. 204-207.
  • Show author(s) (1999). Hyperosmotic pre-treatment reduces infarct size in the rat heart. Physiological Research. 331-340.
  • Show author(s) (1999). A survey of hypnotic use in geriatric institutions in Sogn og Fjordane, Norway. Aging Clinical and Experimental Research. 50-55.
  • Show author(s) (1998). Use of hypnotics among patients in geriatric institutions. International Journal of Geriatric Psychiatry. 846-851.
  • Show author(s) (1997). Manganese and the heart: acute cardiodepression and myocardial accumulation of manganese. Acta Physiologica Scandinavica. 33-40.
  • Show author(s) (1997). Effects of MnDPDP, DPDP--, and MnCl2 on cardiac energy metabolism and manganese accumulation. An experimental study in the isolated perfused rat heart. Investigative Radiology. 205-211.
  • Show author(s) (1996). Protection induced by a brief ischemic episode in the Langendorff perfused rat heart. Academic Radiology. 645-650.
  • Show author(s) (1996). Pretreatment with ischaemia attenuates acute epirubicin-induced cardiotoxicity in isolated rat hearts. Pharmacology and Toxicology. 381-386.
  • Show author(s) (1996). Effects of eicosapentaenoic acid and docosahexaenoic acid diet supplement on tolerance to the cardiotoxicity of epirubicin and to ischaemia reperfusion in the isolated rat heart. Pharmacology and Toxicology. 65-72.
  • Show author(s) (1995). Preconditioning by brief ischemic episodes in the isolated rat heart assessed by 31P NMR spectroscopy: dissociation between metabolic and functional recovery? Scandinavian Journal of Clinical and Laboratory Investigation. 67-78.
  • Show author(s) (1995). Effects of MnDPDP, DPDP-- and MnCl2 upon cardiac function: an experimental study in the Langendorff perfused rat heart. Investigative Radiology. 159-167.
  • Show author(s) (1995). Contractile responses to electrolyte changes during coronary bolus perfusion: a comparative study in isolated rat, guinea pig and rabbit hearts. Investigative Radiology. 173-180.
  • Show author(s) (1994). Lidocaine interactions with exogenous and endogenous adenosine in the isolated rat heart. Pharmacology and Toxicology. 212-217.
  • Show author(s) (1994). Ischemic episodes less than five min produce preconditioning but not stunning in the isolated rat heart. Acta Physiologica Scandinavica. 281-291.
  • Show author(s) (1994). Early detection of regional myocardial ischemia in ex vivo piglet hearts: MR imaging with magnetization transfer. Journal of Magnetic Resonance Imaging. 603-608.
  • Show author(s) (1993). Infusion of EPA and DHA lipid emulsions: effects on heart lipids and tolerance to ischaemia-reperfusion in the isolated rat heart. Scandinavian Journal of Clinical and Laboratory Investigation. 31-39.
  • Show author(s) (1993). Effect of GD-DTPA-BMA on magnetization transfer: Application to rapid imaging of cardiac ischemia. Journal of Magnetic Resonance Imaging. 31-39.
Lecture
  • Show author(s) (2019). Sonoporation and gemcitabine delivery in pancreatic cancer cell lines.
  • Show author(s) (2015). The Drug Information Center in 2015 – still a valid concept?
  • Show author(s) (2010). Antidepressiva og interaksjoner.
Academic lecture
  • Show author(s) (2018). Discontinuation of drug treatment due to side effects after first-time percutaneous coronary intervention: a patient perspective.
  • Show author(s) (2013). Risk perception among health care professionals and the public: Experience from regional medicines and pharmacovigilance centres (RELIS) in Norway.
  • Show author(s) (2013). Cedia Assays For Buprenorphine, Methadone, And Eddp In Urine – Simple Methods, But Sufficient For The Purpose?
  • Show author(s) (2011). Risk perception and drug information needs for pregnant women with epilepsy – a qualitative study.
  • Show author(s) (2011). A question-answer pair (QAP) database integrated with websites for the regional medicines information and pharmacovigilance centres in Norway (RELIS).
Editorial
  • Show author(s) (2009). Legemiddelhåndtering hos barn og eldre. Tidsskrift for Den norske legeforening. 1731-1731.
Reader opinion piece
  • Show author(s) (2020). Ny bivirkningsforskrift gir undervisningsbehov. Tidsskrift for Den norske legeforening.
  • Show author(s) (2018). Ciprofloxacin and acute aortic valve damage. Medical Hypotheses. 35-35.
  • Show author(s) (2014). Re: Glem ikke Marevanen! Tidsskrift for Den norske legeforening. 2125-2125.
  • Show author(s) (2009). Warnings against candesartan in pregnancy are not implemented in physicians' practice. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 235-235.
Short communication
  • Show author(s) (2021). Acute Myocardial Injury in a Patient with Attention Deficit Hyperactivity Disorder and History of Substance Abuse: A Multimodality Imaging Point of View. Journal of Cardiovascular Development and Disease (JCDD).
  • Show author(s) (2019). Short communication: Distribution of psychotropic drugs into lipoproteins. Therapeutic Drug Monitoring. 766-771.
  • Show author(s) (2017). Shortage of digitoxin and switching to digoxin in Norway: A retrospective study of blood samples submitted to a clinical pharmacology laboratory. Basic & Clinical Pharmacology & Toxicology. 74-77.
  • Show author(s) (2017). Risk perception regarding drug use in pregnancy. American Journal of Obstetrics and Gynecology. 375-378.
  • Show author(s) (2017). Physicians' questions concerning drug use among older patients: experience from Norwegian drug information centres (RELIS) in the period 2010-2015. Aging Clinical and Experimental Research. 1-4.
  • Show author(s) (2016). Legemiddelbruk hos blodgivere. Tidsskrift for Den norske legeforening. 718-720.
  • Show author(s) (2016). Challenges in psychopharmacology: a drug information centre perspective. Journal of Clinical Pharmacy and Therapeutics. 4-6.
  • Show author(s) (2014). En mann i 70-årene med infeksjon og alvorlig syre-base-forstyrrelse. Tidsskrift for Den norske legeforening. 315-319.
  • Show author(s) (2013). Medikamentell behandling av nevropatiske smerter. Tidsskrift for Den norske legeforening. 971-973.
  • Show author(s) (2009). Ulike doseringsanbefalinger for jern. Norsk Farmaceutisk Tidsskrift. 21-21.
Academic anthology/Conference proceedings
  • Show author(s) (2011). Liver Biopsy in Modern Medicine. IntechOpen.
Thesis at a second degree level
  • Show author(s) (2018). Sentralstimulerende stoffer og kardiovaskulære hendelser - en litteraturstudie.
  • Show author(s) (2018). Drug interactions and availability of drug monitoring – A study of nursing home patients in Bergen, Norway.
Masters thesis
  • Show author(s) (2021). LipoClear og ultrasentrifugering som metode for fjerning av liporotein i serum.
  • Show author(s) (2019). Evaluering av nettjenesten TryggMammamedisin.no-en deskriptiv studie av en tjeneste for legemiddelinformasjon til gravide og ammende.
  • Show author(s) (2018). A literature-based concept analysis in supply chain risk management for the Norwegian Atlantic salmon industry.
  • Show author(s) (2017). Val av antiflogistika ved Ortopedisk klinikk i Helse Bergen.
  • Show author(s) (2014). Legers risikopersepsjon ved bruk av legemidler i graviditeten. Endres denne ved informasjon og råd fra RELIS.
  • Show author(s) (2012). Using magnetic resonance imaging to assess the extent of infarction and salvageable myocardial tissue after pharmacological postconditioning in an experimental ex vivo model.
  • Show author(s) (2012). Evaluering av pilotprosjektet Trygg Mammamedisin-en kvantititativ og kvalitativ studie av en legemiddelinformasjonstjeneste for gravide og ammende.
  • Show author(s) (2011). Analyse av psykofarmaka-Metodeutvikling for kromatografisk analyse av utvalgte antidepressiva og antipsykotika i serum.
  • Show author(s) (2009). Spontanrapportering av bivirkninger hos barn i Norge for perioden 1998-2007.
  • Show author(s) (2008). Information on drug interactions: A comparison of two common sources of drug information in Norway.
  • Show author(s) (2008). A rat model to assess interventions to reduce cardiotoxicity of anthracyclines. Does pretreatment with morphine reduce cardiotoxicity of doxorubicin?
Popular scientific article
  • Show author(s) (2015). Inspirerende foredrag om antibiotikaresistens. Norsk Farmaceutisk Tidsskrift.
  • Show author(s) (2015). Folk dør av hemmelige bivirkninger. Bergens Tidende.
Feature article
  • Show author(s) (2022). Fornyet vurdering-stoler du på legen? Tidsskrift for Den norske legeforening. 682-682.
Letter to the editor
  • Show author(s) (2022). The possibility of hypersensitivity myocarditis following COVID-19 vaccines: Implications for contrast echocardiography. Cardiology.
  • Show author(s) (2022). Second opinion in pharmacotherapy of ADHD – do not postpone it! Clinical Therapeutics.
  • Show author(s) (2021). Ultrasound and microbubble assisted drug delivery – a clinical pharmacological perspective. Pharmacological Research.
  • Show author(s) (2019). Stability of antidepressants and antipsychotics in gel separator tubes. Therapeutic Drug Monitoring. 249-250.
  • Show author(s) (2019). Disproportionality analysis for identification of drug safety questions in a database shared by the Norwegian network of drug information centres (RELIS). European Journal of Clinical Pharmacology.
  • Show author(s) (2016). Benefits of a national network of drug information centres: RELIS. European Journal of Clinical Pharmacology. 125-126.
  • Show author(s) (2009). Legemidler ved pollenallergi, graviditet og amming. Tidsskrift for Den norske legeforening. 1354-1354.
Doctoral dissertation
  • Show author(s) (2020). Drug delivery in pancreatic cancer.
  • Show author(s) (2015). Cardiotoxicity of Doxorubicin. A Study of Methods and Protective Interventions in Rat Models.
  • Show author(s) (2013). Drug information in pregnancy - attitudes and needs among pregnant women and physicians.
  • Show author(s) (2012). E-learning: A study of students' attitudes and learning outcome when using blended learning with integration of multimedia instructions.
  • Show author(s) (1996). Myocardial protection : functional and metabolic characteristics of two endogeneous protective principles. 118.
Interview
  • Show author(s) (2010). Håndtering av seponeringsreaksjoner.
Academic chapter/article/Conference paper
  • Show author(s) (2011). Adverse Effects of Drugs and Toxins on the Liver. 27 pages.
  • Show author(s) (2010). Legemiddelinformasjon. 9 pages.
Abstract
  • Show author(s) (2021). Perceptions of efficacy and safety of generic medicines in patients after percutaneous coronary intervention. European Heart Journal.
  • Show author(s) (2021). Communication of Potential Adverse Drug Reactions in Patients Undergoing Percutaneous Coronary Intervention. Circulation.
  • Show author(s) (2019). Patients’ Perceptions of Generic Drugs After Percutaneous Coronary Intervention: A Multicentre Cohort Study. Circulation.
  • Show author(s) (2017). Factors affecting in-hospital sleep-wake pattern in octogenarians during the early postoperative phase after transcutaneous aortic valve replacement. European Journal of Cardiovascular Nursing. 53.
  • Show author(s) (2016). Ultrasound and microbubble enhanced treatment of inoperable pancreatic adeonocarcinoma. Journal of Clinical Oncology.
  • Show author(s) (2015). The Drug Information Centre in 2015 – still a valid concept? Clinical Therapeutics. e168-e168.
  • Show author(s) (2013). Joint Medicines Information and Pharmacovigilance Services Could Improve Detection of New Drug Safety Information. Drug Safety. 910-910.
  • Show author(s) (2011). PREVALENCE OF PREGABALIN IN URINE SAMPLES FROM PATIENTS TREATED FOR SUBSTANCE-DEPENDENCY. Basic & Clinical Pharmacology & Toxicology. 79-79.
  • Show author(s) (2011). Gender Differences in Adverse Drug Reaction (ADR) Reporting in Children in Norway 2001-2010. Drug Safety. 979-979.
  • Show author(s) (2009). Ultra high field 7T MRI of the ex vivo perfused rat heart. Cardiology. 105-106.
  • Show author(s) (2009). Ten Years of Spontaneous Reporting of Adverse Drug Reactions in Children in Norway. Drug Safety. 924-924.
  • Show author(s) (2009). Drug use in pregnancy-are there differences between common sources of information? Pharmacy World & Science (PWS). 49-49.
  • Show author(s) (2008). Use of antibacterials and urinary tract prophylactic agents in Norwegian nursing homes. Pharmacoepidemiology and Drug Safety. S48-S49.
  • Show author(s) (2008). New methods to study complexity of drug information queries. Pharmacoepidemiology and Drug Safety. S50-S51.
  • Show author(s) (2008). Drug use in pregnancy - Service and clinical impact of drug information centres. Pharmacoepidemiology and Drug Safety. S157-S158.
  • Show author(s) (2007). Hepatitis caused by a natural product? Drug Safety. 944-944.
  • Show author(s) (2007). Drug use in pregnancy: Are there differences between common sources of information? Drug Safety. 954-954.
Poster
  • Show author(s) (2021). Establishing an LC-MS/MS method as a tool in a TDM approach when treating multiple sclerosis with monoclonal antibodies.
  • Show author(s) (2019). role of intracellular cytidine deaminase activity for gemcitabine metabolism in pancreatic cancer cell lines.
  • Show author(s) (2019). Sonoporation and gemcitabine delivery in pancreatic cell lines.
  • Show author(s) (2019). Sonoporation and gemcitabine delivery in pancreatic cancer cell lines.
  • Show author(s) (2019). Intracellular cytidine deaminase and gemcitabine metabolism in three pancreatic cancer cell lines.
  • Show author(s) (2019). Intracellular cytidine deaminase and gemcitabine metabolism in three pancreatic cancer cell lines.
  • Show author(s) (2019). Experience with the internet-based service SafeMummyMedicine: A Norwegian medicines information service for pregnant and breastfeeding women.
  • Show author(s) (2018). Octogenarian patients’ experiences with hypnotics in relations to sleep disturbance and delirium after aortic valve replacement.
  • Show author(s) (2018). Liquid Chromatography Quadrupole Time of Flight Mass Spectrometry as a diagnostic tool in clinical toxicology.
  • Show author(s) (2016). Psychotropic Drug Exposure and Hip Fractures.
  • Show author(s) (2015). PHYSICIANS’ PERCEPTION OF TERATOGENIC RISK AND CONFIDENCE IN PRESCRIBING INFLUENCE OF NORWEGIAN MEDICINES INFORMATION CENTRES.
  • Show author(s) (2014). Stability of gemcitabine and metabolite in blood samples from pancreatic cancer patients.
  • Show author(s) (2013). CEDIA for buprenorfin, metadon og EDDP i urin- er det enkleste godt nok?
  • Show author(s) (2012). Hvilke spørsmål får RELIS om alternativ medisin – og hvordan svarer vi?
  • Show author(s) (2012). Diazoxide protects against doxorubicin-induced cardiotoxicity in the rat.
  • Show author(s) (2010). Prevention of urinary tract infections in Norwegian nursing homes.
  • Show author(s) (2010). Hypersensitivity Reactions to Drugs: A Retrospective Analysis of Clinical Characteristics of Patients Consulting for Suspected Drug Hypersensitivity in an Allergy Center in Norway.
  • Show author(s) (2010). Determination of hydrogen peroxide in isolated rat hearts.
  • Show author(s) (2009). 10 years of adverse drug reaction reporting among children.
  • Show author(s) (2008). Fabry disease: Unusual symptoms in two male children treated with lamotrigine and fabrazyme, respectively.
  • Show author(s) (2007). Drug use in pregnancy – are there differences between common sources of information?
  • Show author(s) (2003). A free web-based, full-text drug information database.
  • Show author(s) (2001). A web-based full-text drug information database (RELISWeb).
  • Show author(s) (2000). Is problem-oriented drug information a method to change clinical practice?
  • Show author(s) (1999). Polypharmacy among hospitalized patients with rheumatoid arthritis or polyarthritis.
  • Show author(s) (1998). Who needs a drug information centre? An evaluation.
  • Show author(s) (1998). Who needs a drug information centre? An evaluation.
Academic literature review
  • Show author(s) (2020). Ultrakort om farmakogenetikk. Utposten. 42-43.
  • Show author(s) (2020). SafeMotherMedicine: Aiming to increase women’s empowerment in use of medications during pregnancy and breastfeeding. Maternal and Child Health Journal. 531-536.
  • Show author(s) (2020). Review of questions concerning clinical drug interactions in ADHD treatment from physicians in Norway. Frontiers in Pharmacology.
  • Show author(s) (2019). Norwegian drug information centres strongly promote person-centred and personalised medicine: a brief report on the achievements and strategy. EPMA Journal. 109-114.
  • Show author(s) (2019). Drug information centres and their provision of decision support: The Scandinavian experience. Journal of Clinical Pharmacy and Therapeutics. 489-492.
  • Show author(s) (2017). Ultrakort om biologiske legemidler. Norsk Farmaceutisk Tidsskrift. 24-25.
  • Show author(s) (2010). Håndtering av seponeringsreaksjoner. Tidsskrift for Den norske legeforening. 37-38.
  • Show author(s) (2009). Pregabalin og misbrukspotensial. Tidsskrift for Den norske legeforening. 186-187.
  • Show author(s) (2009). Hestekastanje-naturlegemiddel mot venøs insuffisiens. Tidsskrift for Den norske legeforening. 420-422.
  • Show author(s) (2008). Vareniklin (Champix)-nytt legemiddel for røykeavvenning. Tidsskrift for Den norske legeforening. 1962-1963.
  • Show author(s) (2008). Dosering av legemidler ved over-og undervekt. Tidsskrift for Den norske legeforening. 1843-1844.
  • Show author(s) (2006). Legemiddelinformasjonsmetoder for å påvirke legers praksis? Norsk Farmaceutisk Tidsskrift. 24-26.
  • Show author(s) (2004). Delivering balanced and quality drug information to professionals. International Pharmacy Journal. 19-20.
  • Show author(s) (2002). Reseptfritt-problemfritt for brukeren? Norsk Farmaceutisk Tidsskrift. 23-23.
  • Show author(s) (2001). Spørsmål og svar-nå på Internett: www.relis.no/database. Norsk Farmaceutisk Tidsskrift. 21-22.
  • Show author(s) (2000). Statiner og muskelbivirkninger. Tidsskrift for Den norske legeforening. 3729-3731.
  • Show author(s) (1996). Kryssreaksjoner mellom ACE-hemmere ved angioødem og eksfoliativ dermatitt? Tidsskrift for Den norske legeforening. 2348-2348.
Website (informational material)
  • Show author(s) (2019). Observasjon etter injeksjon med Zypadhera.
  • Show author(s) (2016). Venlafaksin og risiko for kardiovaskulære bivirkninger.
  • Show author(s) (2016). Dabigatran og interaksjon med statiner?
Article in business/trade/industry journal
  • Show author(s) (2022). Bytte legemidler – hva bør man tenke på? Utposten. 54-55.
  • Show author(s) (2015). Trygg Medisin - ny publikumstjeneste. Utposten. 56-56.
  • Show author(s) (2005). Imigran til sulfaallergiker. Utposten. 43-43.
  • Show author(s) (2001). RELIS spørsmål og svar-database på Internett. Utposten. 38-39.
  • Show author(s) (1999). Polyfarmasi hos en eldre pasient. Utposten. 36-38.
  • Show author(s) (1998). Zantac (ranitidin) og effekt på sæd. Utposten. 31-31.
  • Show author(s) (1997). Bivirkninger av Betolvex injeksjon? Utposten. 254-254.
  • Show author(s) (1996). Sopp og amming. Utposten. 284-285.
Chapter
  • Show author(s) (2018). Legemiddelinformasjon. 192-203. In:
    • Show author(s) (2018). Samfunnsfarmasi. Fagbokforlaget.

More information in national current research information system (CRIStin)